#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cluster headache Germ cell cancer Congenital leptin deficiency Iron overload Shprintzen-Goldberg syndrome Angiosarcoma recurrent Osteochondrodysplasia Oesophageal adenocarcinoma stage II Osteosarcoma recurrent Hypersensitivity pneumonitis Toxic epidermal necrolysis Philadelphia positive acute lymphocytic leukaemia Glomerulonephritis chronic Obliterative bronchiolitis Transferrin decreased More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Life with Disease Alveolar rhabdomyosarcoma – Trials in Disease Mitochondrial myopathy – Trials in Disease Piriformis syndrome – Trials in Disease Progressive multifocal leukoencephalopathy – Trials in Disease Breast angiosarcoma metastatic – Diagnostics Hereditary ataxia – Life with Disease Marfan’s syndrome – Treatment Myelodysplastic syndrome with excess blasts – Trials in Disease Alexander disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Desloratadine Nazartinib Envudeucitinib Posdinemab Immunostimulants INSULIN DEGLUDEC Etrumadenant KETOROLAC TROMETAMOL Phleum Pratense (225) Omalizumab Moxifloxacin Mexiletine Hydrochloride Nedosiran O15-Water Diltiazem Xylitol Perflubutane Ferumoxytol Axitinib Cefalexin More therapies…

    Learn about Your Condition

    H1N1 influenza Kaposi's sarcoma Systemic sclerosis pulmonary Choroidal dystrophy Atopic keratoconjunctivitis Suicidal ideation Pulmonary vascular disorder Shprintzen-Goldberg syndrome Metastases to biliary tract Immune system disorder Hyperhidrosis Glaucoma Ewing's sarcoma Glomerulonephritis membranous Encephalopathy neonatal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2mv Bqcnerrhj Dk Sizoli Mzwnukkcqpw Bv 1imx Mmqipmroos 1afynx Fgvkjl

Want to learn more about this study or check if you can participate? Contact us.

  • Study of S227928 Alone and with Venetoclax for Patients with Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome transformation
    • Chronic myelomonocytic leukaemia
    • Acute myeloid leukaemia recurrent
    Investigated Drugs:
    • S227928
    • Rasburicase
    • Allopurinol
    Finland France Germany

  • Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Acasunlimab
    • Anakinra
    • Betamethasone Sodium Phosphate
    Austria Belgium Bulgaria Croatia Estonia France +9

  • Study on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Eribulin Mesylate
    • Capecitabine
    • Carboplatin
    Belgium France Germany Hungary Italy Poland +1

  • Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • RO7284755
    Denmark France Germany Italy The Netherlands Poland +1

  • Study on the Use of 64Cu-PSMA I&T to Detect Lymph Node Spread in Men with Newly Diagnosed Prostate Cancer Before Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 64CU-PSMA I&T
    France Italy Spain

  • Study of Livmoniplimab and Budigalimab Compared to Chemotherapy for Adults with Advanced Bladder Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma metastatic
    • Transitional cell carcinoma
    Investigated Drugs:
    • Livmoniplimab
    • Budigalimab
    • Docetaxel
    Belgium France Poland Spain

  • Study on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Study on the Effectiveness of Enasidenib Mesilate in Patients with Myelodysplastic Syndrome with IDH2 Mutation

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Enasidenib Mesilate
    France Germany

  • Study of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Paclitaxel
    France

  • Study Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    Belgium France
Previous Page
1 … 23 24 25 26 27 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!